Zou, Yongjuan Wu, Nan Miao, Chunyu Yue, Hua Wu, Jie Ma, Guanghui
To generate effective immunity post-vaccination, antigens need to be effectively captured and taken up by antigen-presenting cells (APCs) as a prerequisite. Biomimetic designs that mimic natural pathogen-like properties have provided platforms for antigen delivery. However, the structural dynamic properties of pathogens leading to their efficient i...
Van Hoecke, Lien Verbeke, Rein De Vlieger, Dorien Dewitte, Heleen Roose, Kenny Van Nevel, Sharon Krysko, Olga Bachert, Claus Schepens, Bert Lentacker, Ine
...
Published in
Molecular therapy. Nucleic acids
To date, mRNA-based biologics have mainly been developed for prophylactic and therapeutic vaccination to combat infectious diseases or cancer. In the past years, optimization of the characteristics of in vitro transcribed mRNA has led to significant reduction of the inflammatory responses. Thanks to this, mRNA therapeutics have entered the field of...
Bucciol, Giorgia Schaballie, Heidi Schrijvers, Rik Bosch, Barbara Proesmans, Marijke De Boeck, Kris Boon, Mieke Vermeulen, François Lorent, Natalie Dillaerts, Doreen
...
Background The correlation between different methods for the detection of pneumococcal polysaccharide vaccine (PPV) responses to diagnose specific polysaccharide antibody deficiency (SAD) is poor and the criteria for defining a normal response lack consensus. We previously proposed fifth percentile (p5) values of PPV responses as a new cutoff for S...
Matthijs, Anneleen Marguerite Filip Auray, Gaël Boyen, Filip Schoos, Alexandra Michiels, Annelies García-Nicolás, Obdulio Barut, Güliz Tuba Barnier-Quer, Christophe Jakob, Virginie Collin, Nicolas
...
Published in
Veterinary Research
New vaccine formulations that include novel strains of Mycoplasma hyopneumoniae and innovative adjuvants designed to induce cellular immunity could improve vaccine efficacy against this pathogen. The aim of this experimental study was to assess the efficacy of three experimental bacterin formulations based on M. hyopneumoniae field strain F7.2C whi...
Bucciol, Giorgia; 115768; Schaballie, Heidi; Schrijvers, Rik; 60298; Bosch, Barbara; Proesmans, Marijke; 3457; De Boeck, Christiane; Boon, Mieke; 59890; Vermeulen, François; 58463; Lorent, Natalie; Dillaerts, Doreen; 76014;
...
Background: The correlation between different methods for the detection of pneumococcal polysaccharide vaccines (PPV) responses to diagnose specific polysaccharide antibody deficiency (SAD) is poor and the criteria for defining a normal response lack consensus. We previously proposed fifth percentile (p5) values of PPV responses as a new cutoff for...
Petricek, Goranka Hoffmann, Kathryn Vandenbroucke, Anna Divjak, Asja Cosic Mayrhuber, Elisabeth Anne-Sophie Peersman, Wim
Published in
The European journal of general practice
Background: Common cold and influenza result in an increased number of primary care consultations, significant work/school absences and cause a socio-economic burden. Laypeople's perceptions and knowledge regarding common cold and influenza prevention is poorly understood and under-researched.Objectives: Our study explores laypeople's knowledge of ...
Den Boon, S Jit, M Brisson, M Medley, G Beutels, P White, R Flasche, S Hollingsworth, TD Garske, T Pitzer, VE
...
Background Despite the increasing popularity of multi-model comparison studies and their ability to inform policy recommendations, clear guidance on how to conduct multi-model comparisons is not available. Herein, we present guidelines to provide a structured approach to comparisons of multiple models of interventions against infectious diseases. T...
Papp, Kim A Haraoui, Boulos Kumar, Deepali Marshall, John K Bissonnette, Robert Bitton, Alain Bressler, Brian Gooderham, Melinda Ho, Vincent Jamal, Shahin
...
Published in
The Journal of rheumatology
The use of immunosuppressive therapies for immune-mediated disease is associated with an elevated risk of infections and related comorbidities. While many infectious diseases can generally be prevented by vaccines, immunization rates in this specific patient population remain suboptimal, due in part to uncertainty about their efficacy or safety und...
Lô, Gora Sow-Sall, Amina Diop-Ndiaye, Halimatou Babacar, Ndiaye Diouf, Niokhar Ndane Daffé, Sokhna Moumi Ndao, Babacar Thiam, Moussa Mbow, Moustapha Soumboundou, Mamadou Bayo
...
Published in
The Pan African Medical Journal
Introduction Hepatitis B virus (HBV) infection is highly endemic in Senegal. HBV vaccine of all children has been introduced in 1999 and included in the Expanded Programme on Immunization in 2004. The aim of this study was to assess the HBV prevalence and immunity status against HBV amongst children in Senegal. Methods Between March and August 2016...
Machiels, Jean-Pascal Salazar, Ramon Rottey, Sylvie Duran, Ignacio Dirix, Luc Geboes, Karen Wilkinson-Blanc, Christine Pover, Gillian Alvis, Simon Champion, Brian
...
Published in
Journal for ImmunoTherapy of Cancer
BackgroundEnadenotucirev is a chimeric adenovirus with demonstrated preclinical tumor-selective cytotoxicity and a short half-life. Further clinical mechanism of action data showed that enadenotucirev can gain access to and replicate within different types of epithelial tumors. This phase 1 dose escalation study assessed intravenous (IV) dose escal...